Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05563038 · ClinicalTrials.gov registry record · NA

Scrambler Therapy for Post-Stroke Pain

A NA study of Post-Stroke Pain, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05563038 is a NA study of Post-Stroke Pain that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants, above the 18-participant average among 4 other Post-Stroke Pain trials with a reported enrollment target (456% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05563038, a NA study of Post-Stroke Pain, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.

Conditions Studied

Interventions

  • DEVICE Scrambler Therapy for Post Stroke Pain

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-05-15
Est. Completion 2027-12
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05563038

The ClinicalTrials.gov registry entry for NCT05563038 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 18-participant average among 4 other Post-Stroke Pain trials with a reported enrollment target (456% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Stroke Pain appearing as the primary indexed condition, and to 1 intervention - of which Scrambler Therapy for Post Stroke Pain is the first listed.

NCT05563038 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05563038 about?

NCT05563038 is a clinical study titled "Scrambler Therapy for Post-Stroke Pain". The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.

What is the current status of trial NCT05563038?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-05-15. Estimated completion is 2027-12.

What conditions does trial NCT05563038 study?

This clinical trial studies the following conditions: Post-Stroke Pain.

What interventions are being tested in trial NCT05563038?

The interventions under investigation include: Scrambler Therapy for Post Stroke Pain (DEVICE).

Who is sponsoring clinical trial NCT05563038?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05563038 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Stroke Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.